Trial intelligence / Profile preview

REDUCE Trial: Perineural Dexamethasone for Scalp Nerve Blocks

NCT04648358Completed

Sponsor
Beijing Tiantan Hospital
Start
Dec 2020
Primary completion
Jan 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of dexamethasone in postoperative pain (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Duration of analgesia at 48 hours. Started Dec 2020; status: completed.

02

Drugs

dexamethasone
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04648358.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04648358.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call